SQShengkui Qiu

Shengkui Qiu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shengkui Qiu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chengjin Zhao

    Department of Gastroenterology, Nantong First People's Hospital Affiliated Hospital 2 of Nantong University Nantong China

    1 shared publication
  • Chong Tang

    Department of Gastrointestinal Surgery, Affiliated Nantong Clinical College of Nantong University, Nantong First People’s Hospital, Nantong, China

    1 shared publication
  • Shichun Feng

    Department of General Surgery, Nantong First People’s Hospital, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu, China

    1 shared publication
  • Ting Dai

    Department of Gastroenterology, Nantong First People's Hospital Affiliated Hospital 2 of Nantong University Nantong China

    1 shared publication
  • Xuesong Gao

    Department of General Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China

    1 shared publication
  • Yanmei Yang

    Key Laboratory of Reproductive and Genetics, Ministry of Education, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    1 shared publication

Latest Publications

  • Open Access

    Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR‐21‐3p/SMAD7 axis

    by Ting Dai, Shengkui Qiu, Xuesong Gao, Chengjin Zhao, Zhenming Ge, Yanmei Yang, Chong Tang, Shichun Feng

    Gastric cancer (GC) is a highly aggressive malignancy with limited treatment options for advanced‐stage patients. Recent studies have highlighted the role of circular RNA (circRNA) as a novel regulator of cancer progression in various malignancies. However, the underlying mechanisms by which circRNA contributes to the development and progression of GC remain poorly understood. In this study, we utilized microarrays and real‐time quantitative polymerase chain reaction (qRT‐PCR) to identify and validate a downregulated circRNA, hsa_circ_0003251 (referred to as circWNK1), in paired GC and normal tissues. Through a series of in vitro and in vivo gain‐of‐function and loss‐of‐function assays, we demonstrated that circWNK1 exerts inhibitory effects on the proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) of GC cells. Additionally, we discovered that circWNK1 acts as a competitive endogenous RNA (ceRNA) for SMAD7 by sequestering miR‐21‐3p. Our findings were supported by comprehensive biological information analysis, as well as RNA pull‐down, luciferase reporter gene, and western blot assays. Notably, the downregulation of circWNK1 in GC cells resulted in reduced SMAD7 expression, subsequently activating the TGF‐β signaling pathway. Collectively, our study reveals that circWNK1 functions as a tumor suppressor in GC by regulating the miR‐21‐3p/SMAD7‐mediated TGF‐β signaling pathway. Furthermore, circWNK1 holds promise as a potential biomarker for the diagnosis and treatment of GC.